These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

354 related items for PubMed ID: 21339258

  • 21. A pilot trial of serial 18F-fluorodeoxyglucose positron emission tomography in patients with medically inoperable stage I non-small-cell lung cancer treated with hypofractionated stereotactic body radiotherapy.
    Henderson MA, Hoopes DJ, Fletcher JW, Lin PF, Tann M, Yiannoutsos CT, Williams MD, Fakiris AJ, McGarry RC, Timmerman RD.
    Int J Radiat Oncol Biol Phys; 2010 Mar 01; 76(3):789-95. PubMed ID: 19473777
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Implications of false negative and false positive diagnosis in lymph node staging of NSCLC by means of ¹⁸F-FDG PET/CT.
    Li S, Zheng Q, Ma Y, Wang Y, Feng Y, Zhao B, Yang Y.
    PLoS One; 2013 Mar 01; 8(10):e78552. PubMed ID: 24205256
    [Abstract] [Full Text] [Related]

  • 25. FDG uptake in non-small cell lung cancer is not an independent predictor of EGFR or KRAS mutation status: a retrospective analysis of 206 patients.
    Lee SM, Bae SK, Jung SJ, Kim CK.
    Clin Nucl Med; 2015 Dec 01; 40(12):950-8. PubMed ID: 26359571
    [Abstract] [Full Text] [Related]

  • 26. The value of dynamic FDG PET/CT in the differential diagnosis of lung cancer and predicting EGFR mutations.
    Wumener X, Zhang Y, Zang Z, Du F, Ye X, Zhang M, Liu M, Zhao J, Sun T, Liang Y.
    BMC Pulm Med; 2024 May 10; 24(1):227. PubMed ID: 38730287
    [Abstract] [Full Text] [Related]

  • 27. Ratio of standardized uptake value on PET helps predict response and outcome after chemotherapy in advanced non-small cell lung cancer.
    Kaira K, Endo M, Asakura K, Tsuya A, Nakamura Y, Naito T, Murakami H, Takahashi T, Yamamoto N.
    Ann Nucl Med; 2010 Dec 10; 24(10):697-705. PubMed ID: 20824397
    [Abstract] [Full Text] [Related]

  • 28. [Evaluate the value of (18)F-FDG PET-CT imaging in predicting the mutationsin epidermal growth factor receptor in lung adenocarcinoma].
    Ding CY, Yang WP, Guo Z, Sun J, Li YY, Li TR.
    Zhonghua Zhong Liu Za Zhi; 2017 Jul 23; 39(7):528-531. PubMed ID: 28728300
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. The diagnostic and predictive efficacy of 18F-FDG PET/CT metabolic parameters for EGFR mutation status in non-small-cell lung cancer: A meta-analysis.
    Guo Y, Zhu H, Yao Z, Liu F, Yang D.
    Eur J Radiol; 2021 Aug 23; 141():109792. PubMed ID: 34062472
    [Abstract] [Full Text] [Related]

  • 34. Prognostic value of whole-body total lesion glycolysis at pretreatment FDG PET/CT in non-small cell lung cancer.
    Chen HH, Chiu NT, Su WC, Guo HR, Lee BF.
    Radiology; 2012 Aug 23; 264(2):559-66. PubMed ID: 22692034
    [Abstract] [Full Text] [Related]

  • 35. Effect of Epidermal Growth Factor Receptor Mutation on Positron Emission Tomography/Computed Tomography in Lung Cancer.
    Park JS, Park HY, Choi Y.
    Anticancer Res; 2024 Jun 23; 44(6):2681-2687. PubMed ID: 38821597
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Semiquantitative parameters of 18F-FDG PET/CT, gene mutation states of epidermal growth factor receptor and anaplastic lymphoma kinase in prognosis evaluation of patients with lung adenocarcinoma].
    Liao XH, Wang RF, Liu M, Chen XQ, Xiong Y, Nong L, Yin L, Zhang BY, DU YJ.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Oct 20; 53(2):246-254. PubMed ID: 33879893
    [Abstract] [Full Text] [Related]

  • 40. Prognostic value of tumor burden measurement using the number of tumors in non-surgical patients with non-small cell lung cancer.
    Zhang H, Wroblewski K, Pu Y.
    Acta Radiol; 2012 Jun 01; 53(5):561-8. PubMed ID: 22661603
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.